A Simple Model to Help Distinguish Necrotizing Fasciitis from Nonnecrotizing Soft Tissue Infection
Overview
Gynecology & Obstetrics
Authors
Affiliations
Background: Necrotizing fasciitis (NF) has been associated with certain "hard" clinical signs (hypotension, crepitance, skin necrosis, bullae, and gas on x-ray), but these may not always be present. Using results of a previous study, we developed a simple model to serve as an adjunctive tool in diagnosing NF (admission WBC > 15.4 x 10(9)/L or serum sodium [Na] < 135 mmol/L) and determined its ability to distinguish between patients with NF and nonnecrotizing soft tissue infection (non-NF).
Study Design: A retrospective review was conducted of consecutive NF (n=31) and non-NF patients (n= 328) treated at a single institution during an 11-month period. Comparison of admission vital signs, physical examination findings, radiology results, and number of patients meeting model criteria was performed.
Results: Ninety percent of NF patients and 24% of non-NF patients met model criteria (p < 0.0001). The model had a sensitivity of 90%, a specificity of 76%, a positive predictive value of 26%, and a negative predictive value of 99% for diagnosing NF. Nineteen (61%) NF patients had no "hard" signs of NF; the model correctly classified 18 (95%) of these patients.
Conclusions: Admission WBC greater than 15.4 x 10(9)/L and serum Na less than 135mmol/L are useful parameters that may help to distinguish NF from non-NF infection, particularly when classic "hard" signs of NF are absent.
Complicated and deep bacterial skin and soft tissue infections.
Prodinger C, Lechner A, Hintersteininger A, Kern J, Meissnitzer M, Meyersburg D J Dtsch Dermatol Ges. 2025; 23(3):357-375.
PMID: 40052618 PMC: 11887027. DOI: 10.1111/ddg.15493.
Boey J, Lee J, Zhou Z Front Med (Lausanne). 2025; 11():1481388.
PMID: 39845828 PMC: 11753221. DOI: 10.3389/fmed.2024.1481388.
Anshu D, Dwivedi D, Murali D, Mp D Surg Pract Sci. 2025; 13():100163.
PMID: 39845397 PMC: 11749169. DOI: 10.1016/j.sipas.2023.100163.
Ray G, Streeter S, Bateman L, Elliott J, Henderson E J Biomed Opt. 2024; 29(6):066003.
PMID: 38745983 PMC: 11092151. DOI: 10.1117/1.JBO.29.6.066003.
Vittetoe K, Johnson S, Benvenuti T, Schoenecker J, Moore-Lotridge S, Rohde S OTO Open. 2023; 7(3):e68.
PMID: 37565057 PMC: 10410339. DOI: 10.1002/oto2.68.